Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 臨床醫學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/102138
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor黃正雅zh_TW
dc.contributor.advisorCHENG-YA HUANGen
dc.contributor.author陳仁禹zh_TW
dc.contributor.authorJEN-YU CHENen
dc.date.accessioned2026-03-13T16:44:12Z-
dc.date.available2026-03-14-
dc.date.copyright2026-03-13-
dc.date.issued2025-
dc.date.submitted2025-11-21-
dc.identifier.citationReferences
1. Deane KH, Flaherty H, Daley DJ, et al. Priority setting partnership to identify the top 10 research priorities for the management of parkinson's disease. BMJ Open. 2014;4(12):e006434.
2. Inkster LM, Eng JJ. Postural control during a sit-to-stand task in individuals with mild parkinson's disease. Exp Brain Res. 2004;154(1):33-8.
3. Jonsson E, Henriksson M, Hirschfeld H. Age-related differences in postural adjustments in connection with different tasks involving weight transfer while standing. Gait Posture. 2007;26(4):508-15.
4. Conradsson D, Paquette C, Franzén E. Medio-lateral stability during walking turns in older adults. PloS one. 2018;13(6):e0198455.
5. Rogers ME, Rogers NL, Takeshima N, Islam MM. Methods to assess and improve the physical parameters associated with fall risk in older adults. Prev Med. 2003;36(3):255-64.
6. Abou Kassm S, Naja W, Haddad R, Pelissolo A. The relationship between anxiety disorders and parkinson's disease: Clinical and therapeutic issues. Curr Psychiatry Rep. 2021;23(4):20.
7. Jazaeri SZ, Azad A, Mehdizadeh H, et al. The effects of anxiety and external attentional focus on postural control in patients with parkinson's disease. PloS one. 2018;13(2):e0192168.
8. Ehgoetz Martens KA, Lefaivre SC, Beck EN, et al. Anxiety provokes balance deficits that are selectively dopa-responsive in parkinson's disease. Neuroscience. 2017;340:436-444.
9. Hung YT, Wu RM, Huang CY. Differentiation in theta and gamma activation in weight-shifting learning between people with parkinson's disease of different anxiety severities. Geroscience. 2024:46(6):6283-99.
10. Foster PS, Drago V, Yung RC, et al. Anxiety affects working memory only in left hemibody onset parkinson disease patients. Cogn Behav Neurol. 2010;23(1):14-8.
11. Troeung L, Egan SJ, Gasson N. A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in parkinson's disease. PloS one. 2013;8(11):e79510.
12. Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc. 2002;50(10):1629-37.
13. Carey G, Lopes R, Moonen AJH, et al. Cognitive behavioral therapy for anxiety in parkinson's disease induces functional brain changes. J Parkinsons Dis. 2023;13(1):93-103.
14. Costa V, Prati JM, de Oliveira Barreto Suassuna A, Souza Silva Brito T, Frigo da Rocha T, Gianlorenço AC. Physical exercise for treating the anxiety and depression symptoms of parkinson's disease: Systematic review and meta-analysis. J Geriatr Psychiatry Neurol. 2024:8919887241237223.
15. Bucur M, Papagno C. Deep brain stimulation in parkinson disease: A meta-analysis of the long-term neuropsychological outcomes. Neuropsychol Rev. 2023;33(2):307-346.
16. Zheng HB, Liu B, Shen J, Xie F, Ji QM, Zhu XY. Non-invasive brain stimulation for treating psychiatric symptoms in parkinson's disease: A systematic review and meta-analysis. J Clin Neurosci. 2022;106:83-90.
17. Stein DJ, Fernandes Medeiros L, Caumo W, Torres IL. Transcranial direct current stimulation in patients with anxiety: Current perspectives. Neuropsychiatr Dis Treat. 2020;16:161-169.
18. Liu J, Fang J, Wang Z, et al. Transcutaneous vagus nerve stimulation modulates amygdala functional connectivity in patients with depression. J Affect Disord. 2016;205:319-326.
19. Yap JYY, Keatch C, Lambert E, Woods W, Stoddart PR, Kameneva T. Critical review of transcutaneous vagus nerve stimulation: Challenges for translation to clinical practice. Front Neurosci. 2020;14:284.
20. Mondal B, Choudhury S, Banerjee R, et al. Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in parkinson's disease. Front Aging Neurosci. 2023;15:1331575.
21. St Pierre MA, Shinohara M. Transcutaneous vagus nerve stimulation at nonspecific timings during training can compromise motor adaptation in healthy humans. J Neurophysiol. 2023;130(1):212-223.
22. Beckley DJ, Panzer VP, Remler MP, Ilog LB, Bloem BR. Clinical correlates of motor performance during paced postural tasks in parkinson's disease. J Neurol Sci. 1995;132(2):133-8.
23. Shumway-Cook A, Woollacott M. Motor control: Translating research into clinical practice. 2006.
24. Krampe RT. Aging, expertise and fine motor movement. Neurosci Biobehav Rev. 2002;26(7):769-76.
25. Kasahara S, Saito H. Effect of loading parameters on motor performance during a dynamic weight-shift task. Gait Posture. 2015;41(1):100-5.
26. Dijkstra BW, Gilat M, Cofré Lizama LE, et al. Impaired weight-shift amplitude in people with parkinson's disease with freezing of gait. J Parkinsons Dis. 2021;11(3):1367-1380.
27. Harrison EC, Earhart GM. The effect of auditory cues on gait variability in people with parkinson's disease and older adults: A systematic review. Neurodegener Dis Manag. 2023;13(2):113-128.
28. Harrison EC, Horin AP, Earhart GM. Mental singing reduces gait variability more than music listening for healthy older adults and people with parkinson disease. J Neurol Phys Ther. 2019;43(4):204-211.
29. Ebersbach G, Heijmenberg M, Kindermann L, Trottenberg T, Wissel J, Poewe W. Interference of rhythmic constraint on gait in healthy subjects and patients with early parkinson's disease: Evidence for impaired locomotor pattern generation in early parkinson's disease. Mov Disord. 1999;14(4):619-25.
30. Stark-Inbar A, Dayan E. Preferential encoding of movement amplitude and speed in the primary motor cortex and cerebellum. Hum Brain Mapp. 2017;38(12):5970-5986.
31. Zhang X, Li H, Xie T, Liu Y, Chen J, Long J. Movement speed effects on beta-band oscillations in sensorimotor cortex during voluntary activity. J Neurophysiol. 2020;124(2):352-359.
32. Engel AK, Fries P. Beta-band oscillations--signalling the status quo? Curr Opin Neurobiol. 2010;20(2):156-65.
33. Gilbertson T, Lalo E, Doyle L, Di Lazzaro V, Cioni B, Brown P. Existing motor state is favored at the expense of new movement during 13-35 hz oscillatory synchrony in the human corticospinal system. J Neurosci. 2005;25(34):7771-9.
34. Swann N, Tandon N, Canolty R, et al. Intracranial eeg reveals a time- and frequency-specific role for the right inferior frontal gyrus and primary motor cortex in stopping initiated responses. J Neurosci. 2009;29(40):12675-85.
35. Jenkinson N, Brown P. New insights into the relationship between dopamine, beta oscillations and motor function. Trends Neurosci. 2011;34(12):611-8.
36. Rossiter HE, Davis EM, Clark EV, Boudrias MH, Ward NS. Beta oscillations reflect changes in motor cortex inhibition in healthy ageing. Neuroimage. 2014;91(100):360-5.
37. Singh A, Cole RC, Espinoza AI, Brown D, Cavanagh JF, Narayanan NS. Frontal theta and beta oscillations during lower-limb movement in parkinson's disease. Clin Neurophysiol. 2020;131(3):694-702.
38. Muthuraman M, Palotai M, Jávor-Duray B, et al. Frequency-specific network activity predicts bradykinesia severity in parkinson's disease. Neuroimage Clin. 2021;32:102857.
39. Poewe W. Non-motor symptoms in parkinson's disease. Eur J Neurol. 2008;15 Suppl 1:14-20.
40. Broen MP, Narayen NE, Kuijf ML, Dissanayaka NN, Leentjens AF. Prevalence of anxiety in parkinson's disease: A systematic review and meta-analysis. Mov Disord. 2016;31(8):1125-33.
41. Lutz SG, Holmes JD, Ready EA, Jenkins ME, Johnson AM. Clinical presentation of anxiety in parkinson's disease: A scoping review. OTJR (Thorofare N J). 2016;36(3):134-47.
42. Pontone GM, Dissanayka N, Apostolova L, et al. Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of parkinson's disease. NPJ Parkinsons Dis. 2019;5:30.
43. Leentjens AF, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P. Anxiety rating scales in parkinson's disease: A validation study of the hamilton anxiety rating scale, the beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord. 2011;26(3):407-15.
44. Leentjens AF, Dujardin K, Pontone GM, Starkstein SE, Weintraub D, Martinez-Martin P. The parkinson anxiety scale (pas): Development and validation of a new anxiety scale. Mov Disord. 2014;29(8):1035-43.
45. Ehgoetz Martens KA, Ellard CG, Almeida QJ. Anxiety-provoked gait changes are selectively dopa-responsive in parkinson's disease. Eur J Neurosci. 2015;42(4):2028-35.
46. Ehgoetz Martens KA, Silveira CRA, Intzandt BN, Almeida QJ. Overload from anxiety: A non-motor cause for gait impairments in parkinson's disease. J Neuropsychiatry Clin Neurosci. 2018;30(1):77-80.
47. Sawada H, Umemura A, Kohsaka M, et al. Pharmacological interventions for anxiety in parkinson's disease sufferers. Expert Opin Pharmacother. 2018;19(10):1071-1076.
48. Ferreira RM, Alves W, de Lima TA, et al. The effect of resistance training on the anxiety symptoms and quality of life in elderly people with parkinson's disease: A randomized controlled trial. Arq Neuropsiquiatr. 2018;76(8):499-506.
49. Kwok JYY, Kwan JCY, Auyeung M, et al. Effects of mindfulness yoga vs stretching and resistance training exercises on anxiety and depression for people with parkinson disease: A randomized clinical trial. JAMA Neurol. 2019;76(7):755-763.
50. Memarian A, Sanatkaran A, Bahari M. The effect of laughter yoga exercises on anxiety and sleep quality in patients suffering from parkinson’s disease. Biomedical Research and Therapy. 2017;4:1463.
51. Egan SJ, Laidlaw K, Starkstein S. Cognitive behaviour therapy for depression and anxiety in parkinson's disease. J Parkinsons Dis. 2015;5(3):443-51.
52. Beck EN, Wang MTY, Intzandt BN, Almeida QJ, Ehgoetz Martens KA. Sensory focused exercise improves anxiety in parkinson's disease: A randomized controlled trial. PloS one. 2020;15(4):e0230803.
53. Lozano AM, Lipsman N, Bergman H, et al. Deep brain stimulation: Current challenges and future directions. Nat Rev Neurol. 2019;15(3):148-160.
54. Chang B, Mei J, Ni C, Niu C. Functional connectivity and anxiety improvement after subthalamic nucleus deep brain stimulation in parkinson's disease. Clin Interv Aging. 2023;18:1437-1445.
55. Jiang S, Zhan C, He P, et al. Neuronavigated repetitive transcranial magnetic stimulation improves depression, anxiety and motor symptoms in parkinson's disease. Heliyon. 2023;9(8):e18364.
56. Thair H, Holloway AL, Newport R, Smith AD. Transcranial direct current stimulation (tdcs): A beginner's guide for design and implementation. Front Neurosci. 2017;11:641.
57. Chang MC, Kim DY, Park DH. Enhancement of cortical excitability and lower limb motor function in patients with stroke by transcranial direct current stimulation. Brain Stimul. 2015;8(3):561-6.
58. Yuan H, Silberstein SD. Vagus nerve and vagus nerve stimulation, a comprehensive review: Part i. Headache. 2016;56(1):71-8.
59. Yuan H, Silberstein SD. Vagus nerve and vagus nerve stimulation, a comprehensive review: Part ii. Headache. 2016;56(2):259-66.
60. Marano M, Anzini G, Saltarocchi L, et al. Left vagus stimulation modulates contralateral subthalamic β power improving the gait in parkinson's disease. Mov Disord. 2024;39(2):424-428.
61. Zhang H, Cao XY, Wang LN, et al. Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in parkinson's disease: A pilot randomized study. CNS Neurosci Ther. 2023;29(12):3889-3900.
62. George MS, Ward HE, Jr., Ninan PT, et al. A pilot study of vagus nerve stimulation (vns) for treatment-resistant anxiety disorders. Brain Stimul. 2008;1(2):112-21.
63. Sciolino NR, Holmes PV. Exercise offers anxiolytic potential: A role for stress and brain noradrenergic-galaninergic mechanisms. Neurosci Biobehav Rev. 2012;36(9):1965-84.
64. Mahalakshmi B, Maurya N, Lee SD, Bharath Kumar V. Possible neuroprotective mechanisms of physical exercise in neurodegeneration. Int J Mol Sci. 2020;21(16):5895.
65. Burger AM, Van der Does W, Thayer JF, Brosschot JF, Verkuil B. Transcutaneous vagus nerve stimulation reduces spontaneous but not induced negative thought intrusions in high worriers. Biol Psychol. 2019;142:80-89.
66. Sanchez-Perez JA, Gazi AH, Rahman FN, et al. Transcutaneous auricular vagus nerve stimulation and median nerve stimulation reduce acute stress in young healthy adults: A single-blind sham-controlled crossover study. Front Neurosci. 2023;17:1213982.
67. Kvaal K, Ulstein I, Nordhus I, Engedal K. The spielberger state-trait anxiety inventory (stai): The state scale in detecting mental disorders in geriatric patients. International journal of geriatric psychiatry. 2005;20:629-34.
68. Lofredi R, Neumann WJ, Bock A, et al. Dopamine-dependent scaling of subthalamic gamma bursts with movement velocity in patients with parkinson's disease. Elife. 2018;7
69. Brown P, Marsden CD. Bradykinesia and impairment of eeg desynchronization in parkinson's disease. Mov Disord. 1999;14(3):423-9.
70. Aihua L, Lu S, Liping L, Xiuru W, Hua L, Yuping W. A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy. Epilepsy Behav. 2014;39:105-10.
71. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181-4.
72. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for parkinson's disease dementia: Recommendations from the movement disorder society task force. Mov Disord. 2007;22(16):2314-24.
73. Jonasson SB, Nilsson MH, Lexell J. Psychometric properties of the original and short versions of the falls efficacy scale-international (fes-i) in people with parkinson's disease. Health Qual Life Outcomes. 2017;15(1):116.
74. Hulzinga F, Nieuwboer A, Dijkstra BW, et al. The new freezing of gait questionnaire: Unsuitable as an outcome in clinical trials? Mov Disord Clin Pract. 2020;7(2):199-205.
75. Geršak G, Drnovšek J. Electrodermal activity patient simulator. PloS one. 2020;15(2):e0228949.
76. Frangos E, Ellrich J, Komisaruk BR. Non-invasive access to the vagus nerve central projections via electrical stimulation of the external ear: Fmri evidence in humans. Brain Stimul. 2015;8(3):624-36.
77. Hogan N. An organizing principle for a class of voluntary movements. J Neurosci. 1984;4(11):2745-54.
78. Maetzler W, Mancini M, Liepelt-Scarfone I, et al. Impaired trunk stability in individuals at high risk for parkinson's disease. PloS one. 2012;7(3):e32240.
79. Xue J, Lee C, Wakeham SG, Armstrong RA. Using principal components analysis (pca) with cluster analysis to study the organic geochemistry of sinking particles in the ocean. Organic Geochemistry. 2011;42(4):356-367.
80. Maćkiewicz A, Ratajczak W. Principal components analysis (pca). Computers & Geosciences. 1993;19(3):303-342.
81. Ehgoetz Martens KA, Ellard CG, Almeida QJ. Evaluating the link between dopaminergic treatment, gait impairment, and anxiety in parkinson's disease. Mov Disord Clin Pract. 2016;3(4):389-394.
82. McAvoy CR, Moore CC, Aguiar EJ, et al. Cadence (steps/min) and relative intensity in 21 to 60-year-olds: The cadence-adults study. Int J Behav Nutr Phys Act. 2021;18(1):27.
83. Samson MM, Crowe A, de Vreede PL, Dessens JA, Duursma SA, Verhaar HJ. Differences in gait parameters at a preferred walking speed in healthy subjects due to age, height and body weight. Aging (Milano). 2001;13(1):16-21.
84. Su S, Vanvoorden T, Le Denmat P, Zénon A, Braconnier C, Duque J. Transcutaneous vagus nerve stimulation boosts accuracy during perceptual decision-making. Brain Stimul. 2025;18(3):975-986.
85. Kaji R, Urushihara R, Murase N, Shimazu H, Goto S. Abnormal sensory gating in basal ganglia disorders. J Neurol. 2005;252 Suppl 4:Iv13-iv16.
86. Liu R, Qi S, Hao S, Lian G, Luo Y. Using electroencephalography to analyse drivers' different cognitive workload characteristics based on on-road experiment. Front Psychol. 2023;14:1107176.
87. Braun J, Patel M, Woods W, Keatch C, Kameneva T, Lambert E. Frontal and temporo-parietal changes in delta and alpha power accompany stress-induced vasoconstriction and blood pressure response. J Neurophysiol. 2025;133(6):1815-1827.
88. Imperatori C, Farina B, Brunetti R, et al. Modifications of eeg power spectra in mesial temporal lobe during n-back tasks of increasing difficulty. A sloreta study. Front Hum Neurosci. 2013;7:109.
89. Moretti DV, Zanetti O, Binetti G, Frisoni GB. Quantitative eeg markers in mild cognitive impairment: Degenerative versus vascular brain impairment. Int J Alzheimers Dis. 2012;2012:917537.
90. Gliner JA, Mihevic PM, Horvath SM. Spectral analysis of electroencephalogram during perceptual-motor learning. Biological Psychology. 1983;16(1):1-13.
91. Harmony T. The functional significance of delta oscillations in cognitive processing. Front Integr Neurosci. 2013;7:83.
92. Slobounov S, Hallett M, Stanhope S, Shibasaki H. Role of cerebral cortex in human postural control: An eeg study. Clin Neurophysiol. 2005;116(2):315-23.
93. Tzvi E, Verleger R, Münte TF, Krämer UM. Reduced alpha-gamma phase amplitude coupling over right parietal cortex is associated with implicit visuomotor sequence learning. Neuroimage. 2016;141:60-70.
94. Eldemir S, Eldemir K, Saygili F, et al. The effects of standard and modified lsvt big therapy protocols on balance and gait in parkinson's disease: A randomized controlled trial. Brain Behav. 2024;14(3):e3458.
95. Farley BG, Koshland GF. Training big to move faster: The application of the speed-amplitude relation as a rehabilitation strategy for people with parkinson's disease. Exp Brain Res. 2005;167(3):462-7.
96. Morris ME, Iansek R, Matyas TA, Summers JJ. Stride length regulation in parkinson's disease. Normalization strategies and underlying mechanisms. Brain. 1996;119 ( Pt 2):551-68.
97. Peterson DS, Mancini M, Fino PC, Horak F, Smulders K. Speeding up gait in parkinson's disease. J Parkinsons Dis. 2020;10(1):245-253.
98. Williams AJ, Peterson DS, Earhart GM. Gait coordination in parkinson disease: Effects of step length and cadence manipulations. Gait Posture. 2013;38(2):340-4.
99. Mondal B, Choudhury S, Simon B, Baker MR, Kumar H. Noninvasive vagus nerve stimulation improves gait and reduces freezing of gait in parkinson's disease. Mov Disord. 2019;34(6):917-918.
100. Morris R, Yarnall AJ, Hunter H, Taylor JP, Baker MR, Rochester L. Noninvasive vagus nerve stimulation to target gait impairment in parkinson's disease. Mov Disord. 2019;34(6):918-919.
101. Horváth K, Aschermann Z, Ács P, et al. Minimal clinically important difference on the motor examination part of mds-updrs. Parkinsonism Relat Disord. 2015;21(12):1421-6.
102. Zhang H, Shan AD, Wan CH, et al. Transcutaneous auricular vagus nerve stimulation improves anxiety symptoms and cortical activity during verbal fluency task in parkinson's disease with anxiety. J Affect Disord. 2024;361:556-563.
103. Dan R, Růžička F, Bezdicek O, et al. Separate neural representations of depression, anxiety and apathy in parkinson's disease. Sci Rep. 2017;7(1):12164.
-
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/102138-
dc.description.abstract研究背景與目的:平衡與焦慮問題為巴金森患者常見症狀,並會顯著影響患者日常生活功能與增加跌倒風險,尤其處於時間壓力(或高動作速度需求)下,此兩項症狀可能會更加嚴重。經皮迷走神經刺激是一種非侵入性的神經調節介入方式,可能有助於改善焦慮和平衡症狀。然而,目前尚未有研究探討經皮迷走神經刺激結合平衡訓練對巴金森患者於高動作速度需求下,對減輕焦慮和改善平衡的影響。因此,本研究的目的為探討結合經皮迷走神經電刺激與平衡訓練對有焦慮症狀的巴金森患者在不同速度需求下的重心轉移動作、行走能力與焦慮程度的影響。
研究方法:本研究共招募30名有焦慮症狀的巴金森患者,主動迷走神經電刺激組16位和假性迷走神經電刺激組14位。每位受試者接受為期6週的平衡訓練(每週2次、每次60分鐘),隨訓練週數增加動作速度要求。於訓練時分別給予主動迷走神經電刺激或假性迷走神經電刺激。受試者將在訓練前(前測)、訓練後(後測)與後測8週後(追蹤測試)進行重心轉移與行走評估。重心轉移評估分別於三種速度下進行:0.5 Hz、0.1 Hz、複合速度(結合0.6 Hz與0.9 Hz)。於在重心轉移時,同時記錄皮膚電阻訊號(生理焦慮程度)和腦電圖訊號。重心轉移行為參數為:軌跡誤差、轉移幅度、軌跡急動值;腦波參數為:delta (1-4 Hz)、theta (4-8 Hz)、 alpha (8-12 Hz)、beta (12-30 Hz)、low-gamma (30-50 Hz)以及high gamma (50-80 Hz)頻帶的相對頻率強度。行走任務包含單一與雙重作業行走,受試者須分別以自然速度與最快速度行走。行走表現參數為:行走速度、跨步長度、步頻、跨步長度變異性。另以新版世界運動障礙學會巴金森病綜合評量表與巴金森焦慮量表評估受試者的巴金森症狀嚴重度與日常的焦慮程度。
結果:經6週平衡訓練後,僅有主動迷走神經電刺激組在1.0 Hz重心轉移情境下可降低軌跡誤差。而在三種重心轉移情境,兩組皆在後測時呈現較低的重心轉移軌跡急動值,與在追蹤測試時呈現較低的皮膚阻抗數值。腦波結果顯示於後測時,在1.0 Hz情境下,主動迷走神經電刺激組在左側顳葉的delta頻帶強度顯著下降,但假性迷走神經電刺激組則顯著上升。此外,在0.5 Hz與1.0 Hz重心轉移情境,於後測時,主動迷走神經電刺激組的gamma頻帶強度降低、但假性迷走神經電刺激組則上升。於行走表現方面,在自然速度情境,兩組於單一與雙重作業行走的後測時皆增加走路速度;於快速行走情境,相較於假性迷走神經電刺激組,主動迷走神經電刺激組於後測時有較低的步頻。而於臨床量表方面,經過6週的平衡訓練,兩組皆可下降新版世界運動障礙學會巴金森病綜合評量表與巴金森焦慮量表分數,且此進步程度可延續至追蹤測試。
結論與臨床應用:經6週速度強化平衡訓練,具焦慮症狀的巴金森患者無論是接受主動迷走神經電刺激或假性迷走神經電刺激皆可改善重心轉移與行走表現。但主動迷走神經電刺激對快速重心轉移下的精細重心轉移控制提升有更佳的表現,且可避免患者於快速行走時出現小碎步的狀況。本研究結果顯示結合平衡訓練與迷走神經刺激,對具焦慮症狀的巴金森患者是一個安全且有效的訓練模式,然進步成效不一定皆可持續至追蹤測試,建議於具焦慮症狀巴金森患者的訓練需延長訓練間或加強訓練頻率。
zh_TW
dc.description.abstractBackground and Purpose: Balance impairments and anxiety are common symptoms in people with Parkinson’s disease (PD), significantly affecting their daily functioning and increasing the risk of falls. The two symptoms may become even more pronounced under time pressure (or high-speed demand) situations. Transcutaneous vagus nerve stimulation (tVNS), a non-invasive neuromodulation technique, has shown potential in alleviating anxiety and improving balance. However, to date, no studies have investigated the combined effects of tVNS and balance training on reducing anxiety and enhancing balance in people with PD under conditions requiring high movement speed. Therefore, the aim of this study is to examine the effects of combining tVNS with balance training on postural weight-shifting, gait performance, and anxiety levels in people with PD presenting with anxiety symptoms, across speed demands.
Methods: This study recruited 30 PD patients with anxiety. There were 16 participants in the active tVNS group and 14 participants in the sham tVNS group. Each participant underwent a 6-week balance training program (twice a week, 60 minutes per session), with active or sham tVNS applied during the training. The training program emphasized speed-demand for movement. Weight-shifting and walking abilities were assessed before training (pre-test), after training (post-test), and 8 weeks after post-test (follow-up test). The weight-shifting task included three speed conditions: 0.5 Hz, 0.1 Hz, and complex (combined 0.6 Hz with 0.9 Hz). During weight-shifting tasks, skin conductance, and electroencephalography (EEG) signals were recorded. The parameters of weight-shifting task included tracking errors, movement amplitude, tracking jerk. Skin conductance level (SCL) was calculated to represent physiological anxiety. EEG was analyzed for relative power in delta (1-4 Hz), theta (4-8 Hz), alpha (8-12 Hz), beta (12-30 Hz), low-gamma (30-50 Hz), and high-gamma (50-80 Hz) bands at prefrontal, frontal, sensorimotor, parietal-occipital, left temporal, and right temporal area. The walking task included single-task walking and dual-task walking, with natural pace and walking as fast as possible. The walking parameters included walking speed, step length, cadence, and step length variability. In addition, the MDS-sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and Parkinson Anxiety Scale (PAS) were assessed to represent Parkinson severity and daily life anxiety intensity.
Results: After 6-week balance training, only the active tVNS group demonstrated a reduction in tracking error in the 1.0 Hz weight-shift condition. Both groups exhibited lower jerk square mean (JSM) values at post-test, and lower SCL at follow-up test in each weight-shifting condition. EEG results revealed that at post-test of the 1.0 Hz condition, the active tVNS group showed a decreased delta power at left temporal area, whereas the sham group showed an significant increased delta power. Moreover, in the 0.5 Hz and 1.0 Hz conditions, the active tVNS group exhibited decreased gamma power at post-test, while the sham group showed an increased gamma power. In the aspect of walking behavior, both groups increased walking speed at post-test during both single-task and dual-task walking with natural speed. While walking as fast as possible, the active tVNS group showed a lower cadence than the sham group at post-test. Regarding clinical scales, after six weeks of balance training, the scores of the MDS-UPDRS and PAS decreased in both groups, and the improvements were maintained to the follow-up test.
Conclusion and Clinical Application: After 6-week of speed-emphasis balance training, PD with anxiety showed improvements in weight-shifting control and gait performance, regardless receiving active or sham tVNS. However, the active tVNS group demonstrated better fine-tune control for rapid weight-shifting and safe gait pattern for fast walking. These findings suggest that combining balance training with vagus nerve stimulation is a safe and effective intervention for anxious PD patients. However, not all behavior improvements maintained to follow-up test, indicating that longer training durations or higher training frequency might be necessary for the population of PD with anxiety.
en
dc.description.provenanceSubmitted by admin ntu (admin@lib.ntu.edu.tw) on 2026-03-13T16:44:12Z
No. of bitstreams: 0
en
dc.description.provenanceMade available in DSpace on 2026-03-13T16:44:12Z (GMT). No. of bitstreams: 0en
dc.description.tableofcontents致謝 ii
中文摘要 iii
Abstract vi
Chapter 1 Introduction 1
1.1. Overview of posture control and anxiety in Parkinson’s disease with anxiety 1
1.2. Literature Review 3
1.2.1. Effects of speed on postural control in PD 3
1.2.2. Effect of movement speed on brain activities 7
1.2.3. The association between anxiety and postural control 9
1.2.4. Evaluation and non-pharmacologic approaches in anxiety 13
1.2.5. Effects of vagus nerve stimulation on postural control and anxiety in PD 16
1.3. Limitation of previous studies 21
1.4. Purpose and Hypotheses 22
Chapter 2 Methods 24
2.1. Participants 24
2.2. Study procedures and data recording 25
2.3. Data analyses 29
2.4. Statistical analyses 31
Chapter 3 Results 32
3.1. Weight-shifting related findings 32
3.1.1. Weight-shifting task: behavior performance 32
3.1.2. Weight-shifting task: anxiety level 35
3.1.3. Weight-shifting task: brain activity 36
3.2. Walking related findings 46
3.2.1. Walking task: behavior performance 46
3.2.2. Walking task: anxiety level 50
3.3. Clinical scales 51
Chapter 4 Discussion 53
4.1. tVNS effects on weight-shifting control and related brain activities 53
4.2. tVNS effects on walking task 56
4.3. Clinical scale finding 58
4.4. Study limitations and methodology concerns 60
Chapter 5 Conclusion 62
References 63
Figures and tables 71
-
dc.language.isoen-
dc.subject巴金森-
dc.subject焦慮-
dc.subject平衡-
dc.subject迷走神經電刺激-
dc.subject腦電圖-
dc.subjectParkinson’s disease-
dc.subjectanxiety-
dc.subjectbalance-
dc.subjectvagus nerve stimulation-
dc.subjectelectroencephalography-
dc.title結合經皮迷走神經刺激與強化速度之平衡訓練對重心轉移控制之訓練成效:於具焦慮症狀巴金森患者探討zh_TW
dc.titleThe training effects of combining transcutaneous vagus nerve stimulation with speed-emphasis balance training on weight-shifting control: in people with Parkinson’s disease and anxietyen
dc.typeThesis-
dc.date.schoolyear114-1-
dc.description.degree碩士-
dc.contributor.oralexamcommittee吳瑞美;周立偉;蔡宜穎zh_TW
dc.contributor.oralexamcommitteeRUEI-MEI WU;LI-WEI CHOU;YI-YING TSAIen
dc.subject.keyword巴金森,焦慮平衡迷走神經電刺激腦電圖zh_TW
dc.subject.keywordParkinson’s disease,anxietybalancevagus nerve stimulationelectroencephalographyen
dc.relation.page113-
dc.identifier.doi10.6342/NTU202504703-
dc.rights.note同意授權(全球公開)-
dc.date.accepted2025-11-25-
dc.contributor.author-college醫學院-
dc.contributor.author-dept臨床醫學研究所-
dc.date.embargo-lift2026-03-14-
顯示於系所單位:臨床醫學研究所

文件中的檔案:
檔案 大小格式 
ntu-114-1.pdf2.45 MBAdobe PDF檢視/開啟
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved